[Malaria prophylaxis].
Malaria, occurring in 1 to 2% of unprotected travellers to sub-Saharian Africa, remains a real risk because of its potential severity. In Asia or Latin America, the risk appears to be much lower, and in some cases, prevention can be limited to measures to avoid mosquito bites. Chemoprophylaxis by chloroquine-proguanil, mefloquine or, less frequently cyclines, is efficacious but poor compliance and frequent adverse events limits its interest. No regimen is totally effective and malaria must be considered in any traveller coming back from an endemic area with fever, even still receiving an appropriate prophylaxis.
Consultation de médecine tropicale Hôpital Bichat-Claude Bernard, Paris.
O
O
Bouchaud
C
C
Longuet
J P
JP
Coulaud
D000962:Antimalarials / Q000627:therapeutic use*; D004351:Drug Resistance; D019353:Endemic Diseases / Q000706:statistics & numerical data*; D006801:Humans; D008288:Malaria / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control*; D010349:Patient Compliance / Q000523:psychology; D011322:Primary Prevention / Q000379:methods*; D012307:Risk Factors; D014195:Travel
D000962:Antimalarials
Prophylaxie du paludisme.